Iovance Biotherapeutics, Inc. (FRA:2LB)
Germany · Delayed Price · Currency is EUR 2.166
-0.102 (-4.50%)
At close: Jan 30, 2026
Iovance Biotherapeutics Market Cap
Iovance Biotherapeutics has a market cap or net worth of €852.03 million as of January 30, 2026. Its market cap has decreased by -51.33% in one year.
Market Cap
852.03M
Enterprise Value
643.02M
Revenue
213.44M
Ranking
n/a
PE Ratio
n/a
Stock Price
€2.17
Market Cap Chart
Since May 26, 2010, Iovance Biotherapeutics's market cap has increased from 73.63M to 852.03M, an increase of 1,057.25%. That is a compound annual growth rate of 16.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 852.03M | -7.69% |
| Dec 31, 2025 | 923.01M | -57.63% |
| Dec 31, 2024 | 2.18B | 15.73% |
| Dec 29, 2023 | 1.88B | 99.45% |
| Dec 30, 2022 | 943.75M | -64.17% |
| Dec 31, 2021 | 2.63B | -52.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gelsenwasser AG | 1.80B |
| tonies SE | 1.14B |
| Sedlmayr Grund und Immobilien AG | 932.55M |
| Berliner Effektengesellschaft AG | 879.96M |
| Northern Data AG | 842.90M |
| Maschinenfabrik Berthold Hermle AG | 830.00M |
| Paul Hartmann AG | 763.62M |
| EUROKAI GmbH & Co. KGaA | 707.09M |